THE IMPORTANCE OF EARLY DIAGNOSIS OF CANCER: MODERN BIOMARKERS AND SCREENING TECHNOLOGIES

Authors

  • Ma’ripov Suxrob To’ychiboy o’g’li Kimyo International University in Tashkent Faculty of Medicine, 1st-year student Author
  • Maksumova Munura Abduganiyevna Scientific supervisor: Author

Keywords:

Cancer, molecular diagnostics, early detection, biomarkers, liquid biopsy, circulating tumor DNA (ctDNA), multi-cancer early detection (MCED) tests, screening, artificial intelligence, Uzbekistan.

Abstract

The article thoroughly discusses key concepts such as “liquid biopsy,” “circulating tumor DNA,” and “multi-cancer early detection tests,” highlighting their differences from traditional diagnostic methods. In addition, the current state of oncological services in the Republic of Uzbekistan, existing challenges, and promising directions for the development of early diagnosis systems are analyzed, including personnel training, infrastructure development, and strengthening international cooperation.

References

1.World Health Organization (WHO). (2022). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. 1-bet. Ishlatilgan joy: Kirish qismi.

2.O‘zbekiston Respublikasi Sog‘liqni Saqlash Vazirligi, Respublika Onkologiya ilmiy-markazi. (2023). O‘zbekiston Respublikasida onkologik kasalliklar statistikasi: 2022-yil hisoboti. Toshkent. 45, 47, 52-betlar. Ishlatilgan joy: Kirish qismi va 1.1-bo‘lim.

3.Sung, H., Ferlay, J., Siegel, R. L., et al. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209-249. 12-bet. Ishlatilgan joy: Kirish qismi.

4.International Agency for Research on Cancer (IARC). (2021). World Cancer Report: Cancer Research for Cancer Prevention. Lyon, France. 5-bet. Ishlatilgan joy: 1.1-bo‘lim.

5.Mariotto, A. B., Yabroff, K. R., Shao, Y., et al. (2011). Projections of the Cost of Cancer Care in the United States: 2010–2020. Journal of the National Cancer Institute, 103(2), 117-128. 120-bet. Ishlatilgan joy: 1.2-bo‘lim.

6.Mandelblatt, J. S., Cronin, K. A., Bailey, S., et al. (2009). Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms. Annals of Internal Medicine, 151(10), 738-747. 334-bet. Ishlatilgan joy: 1.2-bo‘lim.

7.King, M. C., Marks, J. H., & Mandell, J. B. (2003). Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2. Science, 302(5645), 643-646. 112-bet. Ishlatilgan joy: 2.1-bo‘lim.

8.Lynch, T. J., Bell, D. W., Sordella, R., et al. (2004). Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib. New England Journal of Medicine, 350(21), 2129-2139. 78-bet. Ishlatilgan joy: 2.1-bo‘lim.

9.Le, D. T., Uram, J. N., Wang, H., et al. (2015). PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. New England Journal of Medicine, 372(26), 2509-2520. 95-bet. Ishlatilgan joy: 2.1-bo‘lim.

10.Wan, J. C. M., Massie, C., Garcia-Corbacho, J., et al. (2017). Liquid Biopsies Come of Age: Towards Implementation of Circulating Tumour DNA. Nature Reviews Cancer, 17(4), 223-238. 156-bet. Ishlatilgan joy: 2.2-bo‘lim.

11.Alix-Panabières, C., & Pantel, K. (2021). Circulating Tumor Cells: Liquid Biopsy of Cancer. Clinical Chemistry, 59(1), 110-118. 201-bet. Ishlatilgan joy: 2.2-bo‘lim.

12.Aebersold, R., & Mann, M. (2016). Mass-Spectrometric Exploration of Proteome Structure and Function. Nature, 537(7620), 347-355. 189-bet. Ishlatilgan joy: 2.3-bo‘lim.

13.Spratlin, J. L., Serkova, N. J., & Eckhardt, S. G. (2009). Clinical Applications of Metabolomics in Oncology: A Review. Clinical Cancer Research, 15(2), 431-440. 167-bet. Ishlatilgan joy: 2.3-bo‘lim.

14.Klein, E. A., Richards, D., Cohn, A., et al. (2021). Clinical Validation of a Targeted Methylation-Based Multi-Cancer Early Detection Test Using an Independent Validation Set. Annals of Oncology, 32(9), 1167-1177. 225-bet. Ishlatilgan joy: 2.4-bo‘lim.

15.Cohen, J. D., Li, L., Wang, Y., et al. (2018). Detection and Localization of Surgically Resectable Cancers with a Multi-analyte Blood Test. Science, 359(6378), 926-930. 278-bet. Ishlatilgan joy: 2.4-bo‘lim.

16.Gilbert, F. J., Tucker, L., & Young, K. C. (2016). Digital Breast Tomosynthesis (DBT): A Review of the Evidence for Use as a Screening Tool. Clinical Radiology, 71(2), 141-150. 88-bet. Ishlatilgan joy: 3.1-bo‘lim.

17.Ronco, G., Dillner, J., Elfström, K. M., et al. (2014). Efficacy of HPV-based Screening for Prevention of Invasive Cervical Cancer: Follow-up of Four European Randomised Controlled Trials. The Lancet, 383(9916), 524-532. 76-bet. Ishlatilgan joy: 3.1-bo‘lim.

18.Pickhardt, P. J., Hassan, C., Halligan, S., & Marmo, R. (2011). Colorectal Cancer: CT Colonography and Colonoscopy for Detection—Systematic Review and Meta-analysis. Radiology, 259(2), 393-405. 112-bet. Ishlatilgan joy: 3.1-bo‘lim.

19.Hanna, G. B., Boshier, P. R., Markar, S. R., & Romano, A. (2019). Accuracy and Methodologic Challenges of Volatile Organic Compound–Based Exhaled Breath Tests for Cancer Diagnosis: A Systematic Review and Meta-analysis. JAMA Oncology, 5(1), e182815. 144-bet. Ishlatilgan joy: 3.2-bo‘lim.

20.Gillies, R. J., Kinahan, P. E., & Hricak, H. (2016). Radiomics: Images Are More than Pictures, They Are Data. Radiology, 278(2), 563-577. 199-bet. Ishlatilgan joy: 3.2-bo‘lim.

21.Heitzer, E., Haque, I. S., Roberts, C. E. S., & Speicher, M. R. (2019). Current and Future Perspectives of Liquid Biopsies in Genomics-Driven Oncology. Nature Reviews Genetics, 20(2), 71-88. 305-bet. Ishlatilgan joy: 3.3-bo‘lim.

22.O‘zbekiston Respublikasi Prezidentining Qaroni. (2022). “Onkologik yordam tizimini takomillashtirish va aholiga onkologik kasalliklarni erta aniqlash imkoniyatini kengaytirish chora-tadbirlari to‘g‘risida”gi PQ-346-son Qaroni. Toshkent. 1-bet. Ishlatilgan joy: 4.1-bo‘lim.

23.Abdurakhimov, A. A., Ismailov, S. S., & Khamidova, D. T. (2022). Genetic Predisposition to Breast Cancer in the Uzbek Population: A Pilot Study. Journal of Medical and Biological Research, 15(3), 54-60. 56-bet. Ishlatilgan joy: 4.2-bo‘lim.

Downloads

Published

2026-06-07